1 Ocak 2018 Dergi makalesi Açık Erişim

Eren-Keles, Efsun; Karabulut, Halil Gurhan; Cakmakli, Hasan Fatih; Adakli, Basak; Kose, Serdar Kenan; Ugur-Dincaslan, Handan; Yavuz, Gulsan; Ertem, Mehmet; Tukun, Ajlan

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Karabulut, Halil Gurhan</subfield>
    <subfield code="u">Ankara Univ, Sch Med, Dept Med Genet, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Cakmakli, Hasan Fatih</subfield>
    <subfield code="u">Ankara Univ, Sch Med, Dept Pediat Hematol &amp; Oncol, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Adakli, Basak</subfield>
    <subfield code="u">Istinye Univ, Medicalpk Bahcelievler Hosp, Dept Pediat Hematol &amp; Oncol, Istanbul, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kose, Serdar Kenan</subfield>
    <subfield code="u">Ankara Univ, Sch Med, Dept Biostat, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ugur-Dincaslan, Handan</subfield>
    <subfield code="u">Ankara Univ, Sch Med, Dept Pediat Hematol &amp; Oncol, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Yavuz, Gulsan</subfield>
    <subfield code="u">Ankara Univ, Sch Med, Dept Pediat Hematol &amp; Oncol, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ertem, Mehmet</subfield>
    <subfield code="u">Ankara Univ, Sch Med, Dept Pediat Hematol &amp; Oncol, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Tukun, Ajlan</subfield>
    <subfield code="u">Duzen Labs Grp, Div Med Genet, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">GENETIC TESTING AND MOLECULAR BIOMARKERS</subfield>
    <subfield code="v">22</subfield>
    <subfield code="n">12</subfield>
    <subfield code="c">680-685</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.1089/gtmb.2018.0152</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic Leukemia</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Eren-Keles, Efsun</subfield>
    <subfield code="u">Ankara Univ, Inst Biotechnol, Cent Lab, Tandogan Campus, TR-06110 Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="o">oai:zenodo.org:32507</subfield>
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="2">opendefinition.org</subfield>
    <subfield code="a">cc-by</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2018-01-01</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/32507/files/bib-3453eddf-396c-4cb1-90d6-46e307eff7dc.txt</subfield>
    <subfield code="z">md5:7d4a34ee39700916086e34f6312f79af</subfield>
    <subfield code="s">276</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <controlfield tag="005">20210315184241.0</controlfield>
  <controlfield tag="001">32507</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Aims: Survivin is involved in the inhibition of apoptosis and the regulation of cell division. In addition to wild-type survivin (survivin-wt), at least four splice variants with differential functions (Delta Ex3 and 3B antiapoptotic, and 2 alpha and 2B proapoptotic) have been identified. Survivin is highly expressed in several cancers, including hematological malignancies. Although acute lymphoblastic leukemia (ALL) is the most frequent malignancy in children, studies that investigated survivin expression in ALL are limited, and there is no study on 3B and 2 alpha expression in ALL. Therefore the expression of survivin-wt and its splice variants was investigated in pediatric B-cell ALL patients. Materials and Methods: The expression of survivin-wt and its four splice variants was investigated by quantitative real-time polymerase chain reaction in archival RNA samples of 35 pediatric B-cell ALL patients. Patients were divided into high- and standard-risk groups according to age, white blood cell count, extramedullary involvement, and genetic risk factors; expression of survivin variants was compared between these two risk groups. Results: We found that the ratio of survivin-Delta Ex3/wild type (WT) expression was higher in the low-risk group than in the high-risk group. Conclusion: Comparative analysis between the high- and low-risk B-cell ALL groups indicated that survivin-Delta Ex3/WT expression ratio could potentially be used in risk classification for pediatric B-cell ALL.</subfield>
  </datafield>
</record>